Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-06-02 09:04 am Purchase |
2025-04-15 | 13G | Cara Therapeutics, Inc. CARA |
Ronald A. DePinho | 780,990 8.300% |
780,990 (New Position) |
Filing History |
| 2025-05-02 4:24 pm Purchase |
2025-04-15 | 13G | Cara Therapeutics, Inc. CARA |
Samuel D. Tweardy | 946,974 10.100% |
946,974 (New Position) |
Filing History |
| 2025-05-02 4:21 pm Purchase |
2025-04-15 | 13G | Cara Therapeutics, Inc. CARA |
David J. Tweardy | 652,398 7.000% |
652,398 (New Position) |
Filing History |
| 2025-04-22 2:26 pm Purchase |
2025-04-15 | 13G | Cara Therapeutics, Inc. CARA |
Solas Tvardi Sidecar LLC | 761,287 8.100% |
761,287 (New Position) |
Filing History |
| 2025-04-16 4:15 pm Purchase |
2025-04-15 | 13D | Tvardi Therapeutics, Inc. TVRD |
Vifor (International) Ltd. | 205,465 2.200% |
205,465 (New Position) |
Filing History |
| 2024-12-18 5:10 pm Unchanged |
2024-12-17 | 13D | Cara Therapeutics, Inc. CARA |
Vifor (International) Ltd. | 205,466 13.500% |
0 (Unchanged) |
Filing History |
| 2024-10-30 4:21 pm Unchanged |
2024-10-23 | 13D | Cara Therapeutics, Inc. CARA |
Vifor (International) Ltd. | 205,466 13.500% |
0 (Unchanged) |
Filing History |
| 2024-07-08 4:32 pm Sale |
2024-06-30 | 13G | Cara Therapeutics, Inc. CARA |
BlackRock Inc. BLK |
20,686 1.400% |
-78,043 (-79.05%) |
Filing History |
| 2024-02-13 6:50 pm Sale |
2023-12-31 | 13G | Cara Therapeutics, Inc. CARA |
Bain Capital Life Sciences Opportunities III, LP | 0 0.000% |
-74,890 (Position Closed) |
Filing History |
| 2024-02-13 5:01 pm Sale |
2023-12-29 | 13G | Cara Therapeutics, Inc. CARA |
The Vanguard Group | 73,085 4.830% |
-13,074 (-15.17%) |
Filing History |
| 2024-01-29 3:26 pm Sale |
2023-12-31 | 13G | Cara Therapeutics, Inc. CARA |
BlackRock Inc. BLK |
98,729 6.500% |
-4,103 (-3.99%) |
Filing History |
| 2023-07-25 4:40 pm Unchanged |
2023-07-25 | 13G | Cara Therapeutics, Inc. CARA |
Vifor (International) Ltd. | 205,466 13.700% |
0 (Unchanged) |
Filing History |
| 2023-07-07 4:35 pm Sale |
2023-06-30 | 13G | Cara Therapeutics, Inc. CARA |
BlackRock Inc. BLK |
102,832 6.900% |
-111,904 (-52.11%) |
Filing History |
| 2023-02-09 11:12 am Purchase |
2022-12-30 | 13G | Cara Therapeutics, Inc. CARA |
The Vanguard Group | 86,159 5.770% |
1,916 (+2.27%) |
Filing History |
| 2023-01-26 08:52 am Unchanged |
2022-12-31 | 13G | Cara Therapeutics, Inc. CARA |
BlackRock Inc. BLK |
214,737 14.400% |
0 (Unchanged) |
Filing History |
| 2023-01-20 09:43 am Purchase |
2022-12-31 | 13G | Cara Therapeutics, Inc. CARA |
BlackRock Inc. BLK |
214,737 14.400% |
14,761 (+7.38%) |
Filing History |
| 2022-11-18 4:16 pm Purchase |
2022-11-09 | 13G | Cara Therapeutics, Inc. CARA |
Bain Capital Life Sciences Opportunities III, LP | 74,890 5.000% |
74,890 (New Position) |
Filing History |
| 2022-02-14 6:16 pm Sale |
2021-12-31 | 13G | Cara Therapeutics, Inc. CARA |
FIRST MANHATTAN CO. LLC. | 0 0.000% |
-89,244 (Position Closed) |
Filing History |
| 2022-02-14 11:35 am Sale |
2021-12-31 | 13G | Cara Therapeutics, Inc. CARA |
RHO Ventures VI LP | 22 0.000% |
-77,730 (-99.97%) |
Filing History |
| 2022-02-09 3:33 pm Purchase |
2021-12-31 | 13G | Cara Therapeutics, Inc. CARA |
The Vanguard Group | 84,243 5.670% |
84,243 (New Position) |
Filing History |